ストックスクリーナーアプリを入手
0.3862
4.38%
0.0162
前日終値:
$0.37
開ける：
$0.39
24時間の取引高:
826.59K
Relative Volume:
0.91
時価総額：
$20.39M
収益：
-
当期純損益:
$-24.08M
株価収益率:
-0.4505
EPS:
-0.8572
ネットキャッシュフロー:
$-14.75M
1週間 パフォーマンス:
-17.85%
1か月 パフォーマンス:
-47.38%
6か月 パフォーマンス:
-57.84%
1年 パフォーマンス:
-78.18%
1日の値動き範囲:
$0.3804
$0.41
1週間の範囲:
$0.3622
$0.4923
52週間の値動き範囲:
$0.3622
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
ITRM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.3862 | 19.53M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-28 | アップグレード | Gabelli & Co | Sell → Hold |
| 2021-03-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | ダウングレード | Gabelli & Co | Buy → Sell |
| 2019-12-11 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Iterum Therapeutics Plc (ITRM) 最新ニュース
Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria
Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView
[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan
Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com
Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-19 01:58:59 - newser.com
Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com
Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com
There is no way Iterum Therapeutics Plc (ITRM) can keep these numbers up - Setenews
Visualizing Iterum Therapeutics plc stock with heatmaps2025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Iterum Therapeutics plc stock split attract more investorsCPI Data & Reliable Breakout Forecasts - newser.com
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2025 Earnings Call Transcript - Insider Monkey
Iterum Therapeutics PLC (ITRM) Stock Price, Trades & News - GuruFocus
Iterum projects $5M–$15M in 2026 ORLYNVAH sales while advancing streamlined commercialization and payer access - MSN
Earnings call transcript: Iterum Therapeutics misses Q3 2025 EPS targets By Investing.com - Investing.com South Africa
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... By GuruFocus - Investing.com Canada
Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... - Yahoo Finance
Earnings call transcript: Iterum Therapeutics misses Q3 2025 EPS targets - Investing.com
Iterum Therapeutics (ITRM) Earnings Transcript - The Motley Fool
Iterum Therapeutics plc (ITRM) Q3 FY2025 earnings call transcript - Yahoo Finance
Iterum Therapeutics (ITRM) Reports Revenue Surge with ORLYNVAH L - GuruFocus
Iterum Therapeutics Plc (ITRM) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):